UK Markets closed

Insights on the T-cell Lymphoma Global Market to 2028 - by Lymphoma Type, Therapy and Region

·6-min read
Company Logo
Company Logo

T-cell Lymphoma Market

T-cell Lymphoma Market
T-cell Lymphoma Market

Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Lymphoma is the most common type of blood cancer which occurs when white blood cells called lymphocytes grow and multiply uncontrollably in the human body. Lymphocytes are a part of the immune system of the body, which travel around the body through the lymphatic system and help fight microbial infection.

Lymphocytes are of two types B lymphocytes (B-cells) and T lymphocytes (T-cells). Lymphomas that develop from T lymphocytes are known as non-Hodgkin lymphomas. T-cell lymphoma can affect body parts including spleen, lymph node, bone marrow, blood, and others. T-cell lymphoma can be majorly categorized into two types i.e. peripheral T-cell lymphoma and T-cell lymphoblastic lymphoma. The symptoms associated with T-cell lymphoma depend upon the type of T-cell lymphoma. One of the most common symptom of t-cell lymphoma includes swollen lymph node or nodes. Other symptoms include swollen liver or spleen, skin rash, abnormal blood cell count, and others.

Market Dynamics

The increasing incidence of T-cell lymphoma, rising research and development activities for the development of novel therapeutics for the treatment of T-cell lymphoma are the major factors that are expected to drive growth of the global T-cell lymphoma market over the forecast period. Moreover, increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are expected to boost the global T-cell lymphoma market.

For instance, according to a review article published in the CA: A Cancer Journal for Clinicians in December 2019, it has been estimated that there are around 80,000 people suffering from non-Hodgkin lymphomas (NHL) per year in U.S. and this is expected to increase in the near future.

Key features of the study:

  • This report provides in-depth analysis of the global T-cell lymphoma market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

  • It profiles key players in the global T-cell lymphoma market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

  • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Biocryst Pharmaceuticals Inc., Bristol-Myers Squibb Company, Kyowa Kirin Co., Ltd., Genmab A/S, Seagen Inc., GlaxoSmithKline plc., Johnson and Johnson Private Limited, Elorac, Acrotech Biopharma, Merck and Co. Inc., Novartis AG, SHIONOGI & Co., Ltd., Spectrum Pharmaceuticals Inc., and Bausch Health Companies Inc.

  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

  • The global T-cell lymphoma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global T-cell lymphoma market

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Purview

  • Report Description

  • Market Definition and Scope

  • Executive Summary

  • Market Snippet, By Lymphoma Type

  • Market Snippet, By Therapy

  • Market Snippet, By Region

  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics

  • Drivers

  • Restraints

  • Market Opportunities

  • Impact Analysis

  • Pipeline Analysis

  • PEST Analysis

  • Regulatory Scenario

  • Market Trends

  • Key Highlights

  • Reimbursement Scenario

  • Mergers & Acquisitions

4. Global T-cell Lymphoma Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact

  • Impact on Clinical Trials and Drug Development

  • Government Initiatives

5. Global T-cell Lymphoma Market, By Lymphoma Type, 2017 - 2028, (US$ Mn)

  • Introduction

  • Market Share Analysis, 2021 and 2028 (%)

  • Y-o-Y Growth Analysis, 2018 - 2028

  • Segment Trends

  • Peripheral T-cell Lymphoma

  • Cutaneous T-cell Lymphoma

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Anaplastic Large Cell Lymphoma

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Angio-immuno-blastic T-cell Lymphoma

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Others (Intestinal T-cell Lymphoma, Follicular T-cell lymphoma, etc.)

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • T-cell Lymphoblastic Lymphoma

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global T-cell Lymphoma Market, By Therapy , 2017 - 2028, (US$ Mn)

  • Introduction

  • Market Share Analysis, 2021 and 2028 (%)

  • Y-o-Y Growth Analysis, 2018 - 2028

  • Segment Trends

  • Radiotherapy

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Chemotherapy

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Immunotherapy

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Stem Cell Transplantation

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

  • Others (Antiviral Therapy, etc.)

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global T-cell Lymphoma Market, By Region, 2017 - 2028, (US$ Mn)

8. Competitive Landscape

  • Heat Map Analysis

  • Market Share Analysis

  • F. Hoffmann-La Roche Ltd

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Biocryst Pharmaceuticals Inc.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Bristol-Myers Squibb Company

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Kyowa Kirin Co., Ltd.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Genmab A/S

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Seagen Inc.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • GlaxoSmithKline plc.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Johnson and Johnson Private Limited

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Elorac

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Acrotech Biopharma

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Merck and Co. Inc.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Novartis AG

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • SHIONOGI & Co., Ltd.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Spectrum Pharmaceuticals Inc.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Bausch Health Companies Inc.

  • Company Overview

  • Product Portfolio

  • Financial Overview

  • Key Highlights

  • Market Strategies

  • Analyst Views

9. Section

For more information about this report visit https://www.researchandmarkets.com/r/y7cy7n

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting